Pneumococcal vaccine timing in healthy infants
Part of Immune system & allergy, Infections clinical trials.
This study tests different timing schedules for giving the 13-valent pneumococcal vaccine to healthy 2-month-old infants. The vaccine helps protect babies from serious infections like pneumonia and meningitis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is 2 months old (between 60 and 89 days).
- Your baby was born full-term (at least 37 weeks) and weighed at least 5.5 pounds at birth.
- Your baby has not already received a pneumococcal vaccine.
- Your baby is generally healthy, without serious medical conditions or immune problems.
- Your baby has no known allergies to any vaccine components.
- Your baby is not currently sick or running a fever.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaccine that protects against 21 types of bacteria that cause pneumonia and other infections. It is for healthy infants around 2 months old to see if it works as well as the current vaccine.
This study tests whether a new pneumococcal vaccine (which protects against a serious bacterial infection) is safe in healthy 2-month-old infants. Researchers will watch for side effects and help protect future babies from pneumococcal disease.
This trial tests a new pneumococcal vaccine for babies around 2 months old. It aims to prevent serious infections like pneumonia and meningitis, and may offer protection against more strains than current vaccines.
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
This study tests a new vaccine to protect infants from pneumococcal disease (a serious bacterial infection). Researchers want to see how well the vaccine works and how safe it is in healthy babies aged 2–6 months.
This study tests an investigational vaccine that may protect infants against infections caused by a bacteria called Streptococcus pneumoniae, which can cause pneumonia and other serious illnesses. The vaccine is given to healthy babies around 2 months old, and the study will see how well it works and how safe it is.
Hear when a new Pneumococcal Disease Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.